华纳药厂：股东徐小强减持公司股份129.61万股，减持计划实施完毕

Group 1 - Warner Pharmaceuticals announced that major shareholder Xu Yan and his associate Xu Xiaoqiang reduced their holdings by 1,296,100 shares, accounting for 0.9870% of the company's total shares from September 1 to September 12, 2025, completing the reduction plan [1] - The company's revenue composition for the year 2024 shows that pharmaceutical manufacturing accounted for 99.01% of total revenue, while other businesses contributed 0.99% [1] - As of the latest report, Warner Pharmaceuticals has a market capitalization of 8.4 billion yuan [2]